EDX Medical raises GBP2.7 million to expand employee health screening
24th Aug 2026 16:30
(Alliance News) - EDX Medical Group PLC on Monday said it has raised GBP2.7 million through a share subscription at 14 pence per share. Read More
(Alliance News) - EDX Medical Group PLC on Monday said it has raised GBP2.7 million through a share subscription at 14 pence per share. Read More
(Alliance News) - Stock prices in London were higher at around midday on Monday, despite oil shares weighing as Iran responded defiantly to Washington's threats of the "single greatest financial offensive ever", and ahead of a busy week for US economic data. Read More
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
EDX Medical Group PLC - Cambridge, England-based developer of digital diagnostic products and services - Shares begin trading on AIM under the code EDX and are withdrawn from the Apex Segment of the Aquis Stock Exchange Growth Market. EDX announced its intent to move to AIM in April, when it applied under a "streamlined admission process" called the "AIM Designated Market" route intended for companies previously on Aquis. Read More
(Alliance News) - EDX Medical Group PLC on Monday shared plans to move its listing to London's AIM from the Aquis Exchange, alongside expectations of "record" revenue in financial 2026. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and Thursday and not separately reported by Alliance News: Read More
(Alliance News) - EDX Medical Group PLC on Monday announced a new GBP2 million subscription and convertible loan note deal with its founder and chief scientific officer. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More
(Alliance News) - EDX Medical Group PLC on Friday said it has partnered with the NHS to develop a new pneumonia test for critically ill patients. Read More
(Alliance News) - EDX Medical Group PLC on Monday said it has signed an agreement with Spire Healthcare Group PLC to explore opportunities to utilise new diagnostic products and patient testing services. Read More
EDX Medical Group PLC - Cambridge, England-based firm that develops digital diagnostic products and services to treat cancer, heart disease, and infectious diseases - Announces plans to launch a new "highly accurate" testicular cancer early detection test, which will be available "within weeks" in the UK. Says the TC100 assay, which analyses multiple specific tumour biomarkers and prepares a report for clinicians "using a proprietary AI-powered algorithm", "features exceptional sensitivity...and also detects cancer recurrences at ultra-high accuracy with 100% sensitivity following treatment and during ongoing surveillance of testicular cancer survivors". Says over 30 study reports have confirmed the assay's clinical accuracy and potential clinical usefulness in primary diagnosis, early detection, metastatic disease and recurrence of both seminoma and non-seminoma testicular cancer. Read More
EDX Medical Group PLC - Cambridge, England-based firm that develops digital diagnostic products and services to treat cancer, heart disease, and infectious diseases - Signs master services agreement with Royal Marsden NHS Foundation Trust. The agreement will see EDX supply services to Royal Marsden over a three-year period. EDX Medical Founder & Chief Scientific Officer Chris Evans comments: "I am delighted EDX Medical has now been appointed as a supplier of diagnostic solutions and services to help serve the needs of one of the world's most eminent cancer hospitals." Read More
EDX Medical Group PLC - Cambridge, England-based company that develops digital diagnostic products and services to treat cancer, heart disease, and infectious diseases - Pretax loss widens to GBP1.7 million in the six months to September 30 from GBP1.3 million a year prior. Revenue falls to GBP17.8 million from GBP20.1 million, administrative expenses increase to GBP1.7 million from GBP1.3 million. Read More